Entreprise · 30/03/19941 min de lecture
Akorn, Inc., et al.; Withdrawal of Approval of 18 Abbreviated Antibiotic Applications
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing approval of 18 abbreviated antibiotic applications (AADA's). The holders of the AADA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.